-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Alkermes, Lowers Price Target to $43

Benzinga·03/24/2026 13:01:14
Listen to the news
Piper Sandler analyst David Amsellem maintains Alkermes (NASDAQ:ALKS) with a Overweight and lowers the price target from $45 to $43.